Screening LRRK2 gene mutations in patients with Parkinson’s disease in Ghana-Reference-Cited by-同舟云学术

Screening LRRK2 gene mutations in patients with Parkinson’s disease in Ghana

Published:2011-08-14 Issue:3 Volume:259 Page:569-570
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Cilia Roberto,Sironi Francesca,Akpalu Albert,Cham Momodou,Sarfo Fred Stephen,Brambilla Tiziana,Bonetti Alba,Amboni Marianna,Goldwurm Stefano,Pezzoli Gianni

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-011-6210-y.pdf

Reference10 articles.

1. Klein C, Schlossmacher MG (2006) The genetics of Parkinson disease: implications for neurological care. Nat Clin Pract Neurol 2:136–146

2. Gilks WP, Abou-Sleiman PM, Gandhi S et al (2005) A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet 365:415–416

3. Lesage S, Condroyer C, Lannuzel A et al (2009) Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease. J Med Genet 46(7):458–464

4. Goldwurm S, Zini M, Mariani L et al (2007) Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 68(14):1141–1143

5. Okubadejo N, Britton A, Crews C et al (2008) Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS One 3(10):e3421

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Worldwide Distribution of LRRK2 Mutations in Parkinson’s Disease;Neurodegenerative Disease Management;2023-12

2. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study;The Lancet Neurology;2023-11

3. Transforming Parkinson's Care in Africa (TraPCAf): protocol for a multimethodology National Institute for Health and Care Research Global Health Research Group project;BMC Neurology;2023-10-19

4. Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations;2023-05-07

5. Neurexin 2 p.G849D variant, implicated in Parkinson’s disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells;Journal of Neural Transmission;2022-10-15